Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec;58(12):1430-1434.
doi: 10.1111/ijd.14455. Epub 2019 Apr 10.

Giant basal cell carcinoma: clinical-histological characteristics of 115 cases

Affiliations

Giant basal cell carcinoma: clinical-histological characteristics of 115 cases

Martha R Vaca-Aguilera et al. Int J Dermatol. 2019 Dec.

Abstract

Introduction: Giant basal cell carcinoma (GBCC) is a tumor ≥5 cm in size, with aggressive biological behavior, that represents 1% of basal cell carcinomas (BCC), and studies regarding it are scarce. Our objective was to investigate the clinical-histopathological characteristics of GBCC and the risk factors associated with its development.

Methods: A retrospective study over 8 years included patients with the clinical and histopathological diagnosis of GBCC. Age, sex, localization, size, evolution time, risk factors, and histological variants were compared to conventional BCC. Descriptive and inferential statistics were used, and a value of P < 0.05 was considered statistically significant.

Results: Of 5958 patients with BCC, 115 (2%) of them corresponded to GBCC. The average patient age was 73 ± 11 years, and the male sex (52%) and localization on the head and neck (63%) predominated. Average tumor size was 6.6 ± 2.2 cm, evolution time was 96 ± 86 months, and high-grade histological variants (51%) predominated. The group with GBCC had higher age (P < 0.01), greater frequency in the male sex (P = 0.01), longer evolution time (P < 0.01); a greater prevalence of risk factors (24% vs. 16%, P = 0.01), antecedents of other types of cancer (P = 0.03), and of burns (P = 0.03); and a greater frequency of high-grade histological variants (51% vs. 29%, P < 0.01).

Conclusions: This is the largest series of GBCC published to date. Findings are similar to those previously reported, although the prevalence found here was greater.

PubMed Disclaimer

References

    1. Betti R, Inselvini E, Moneghini L, et al. Giant basal cell carcinomas: report of four cases and considerations. J Dermatol 1997; 24: 317-321.
    1. Archontaki M, Stavrianos SD, Korkolis DP, et al. Giant basal cell carcinoma: clinicopathological analysis of 51 cases and review of the literature. Anticancer Res 2009; 29: 2655-2663.
    1. Greene FL, Page DL, Fleming ID, et al. American Joint Committee on Cancer. Manual for Staging of Cancer, 6th edn. Chicago: Springer, 2002: 202-208.
    1. Zoccali G, Pajand R, Papa P, et al. Giant basal cell carcinoma of the skin: literature review and personal experience. J Eur Acad Dermatol Venereol 2012; 26: 942-952.
    1. Sahl WJ, Snow SN, Levine NS. Giant basal cell carcinoma. Report of two cases and review of the literature. J Am Acad Dermatol 1994; 30: 856-859.

MeSH terms

LinkOut - more resources